CLAIRE EPPS: Open Payments
NPI 1669191151 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,537 in 78 payments from 9 companies in 2025. Trend: 2023 $204 · 2024 $705 · 2025 $1,537
Food & beverage: $1,468Education: $69
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 34 | $425 |
| AstraZeneca Pharmaceuticals LP | 6 | $217 |
| GENZYME CORPORATION | 9 | $199 |
| Actelion Pharmaceuticals US, Inc. | 6 | $186 |
| GlaxoSmithKline, LLC. | 13 | $137 |
| Merck Sharp & Dohme LLC | 5 | $120 |
| Abbott Laboratories | 1 | $113 |
| Insmed, Inc. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 1 | $69 |
Products named: Ohtuvayre, DUPIXENT, OPSUMIT, FASENRA, CARDIOMEMS, NUCALA, Arikayce, ZERBAXA.
Industry payments across SC — which companies pay providers there.
